Mike RossTop StoriesPackaging/Filling7 Success Attributes for a Super-Orphaned Drug Manufacturing SuiteTakeda manufactures one batch of infant botulism treatment every five years. Source plasma only comes from around 30 donors. Hear about their “batch right, first time” approach, because there is no second chance to get it right.Packaging/FillingPharma Manufacturers Need Agile Training Amid Employee TurnoverPackaging/FillingPharmaceutical Drones Prevent Defects in Filling/AssemblyPMMI NewsPACK EXPO East Continues Growth Trajectory With Largest Show to DateAutomation/RoboticsRange of Collaborative Palletizers Feature Integrated Stretch Wrapping